Measles Articles & Analysis
12 news found
Oncovita and the Institut Pasteur have already been working together for several years on the construction and development of new vaccines based on MeasovirR technology, based on the measles vaccine virus. The first candidate under development by Oncovita, MVdeltaC, is an immunotherapeutic treatment for solid tumors and has demonstrated remarkable immunogenic oncolysis ...
ByOncoVITA
This is emphasized by the fact that the WHO lists several vector derived “vaccine candidates” in advanced clinical development against Covid-19, some of which are already on the market.[1] Types of viral vectors in developed using: A number of different viral vectors have been developed using: adenoviruses, adeno-associated viruses (AAV), herpes simplex ...
ByNuvonis
Vaccines protect against a range of diseases, including measles, polio, diphtheria, tetanus, meningitis, influenza and cancer. ...
ByNuvonis
The test-development methodology could also be adapted to other infectious diseases, such as seasonal influenza and measles, and offer improved capability to address mass testing for future waves of COVID-19. ...
“This first clinical trial of a microneedle vaccine for measles and rubella could potentially help reach higher vaccination coverage more easily, which would support our global elimination goals for measles and rubella,” said Dr. Rota Measles is an extremely contagious and acute viral respiratory illness. According to the World ...
A universal vaccine for influenza could be administered prior to need, potentially issued alongside standard childhood vaccinations such as measles/mumps/rubella and varicella. And a shelf-stable delivery method would enable safe storage and distribution worldwide. ...
Further longer-term stability studies are underway, and the Company is planning the immunogenicity studies needed to determine the next development steps to progress the novel vaccine formulations towards clinical trials. Measles and Rubella vaccines are typically maintained in a lyophilized (freeze-dried) form that requires reconstitution in solution prior to injection using a ...
Though they are still used to address previously common infectious diseases (especially “childhood diseases” such as measles, mumps, rubella, and chicken pox), these vaccines must be handled and stored carefully. ...
(Micron) recently received a second tranche of funding ($2.6M) to continue clinical development of its microneedle-based technology for measles and rubella vaccination from the Bill & Melinda Gates Foundation. ...
Malnourished children are five-to-eight times more likely to die from diseases such as diarrhea, pneumonia and measles than are well-nourished children. Nourimanba is a ready-to-use therapeutic food (RUTF) produced by Partners In Health. ...
US$50 per pay period vaccinates 1,300 people against measles, meningitis, polio and other deadly epidemics. US$25 per pay period serves 260 meals to homeless men and women in your community. ...
WHO is helping supply clean water and provide appropriate sanitation, distribute bed nets and essential drugs, and undertake measles vaccinations for children. In Niger, 24 000 people have been displaced, while 12 000 have been displaced in ...